openPR Logo
Press release

Cervical Cancer Vaccine Market:Global Historical Growth & Future Outlook (2017-2025) Demand Analysis & Opportunity Evaluation

03-28-2018 02:33 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Cervical Cancer Vaccine Market:Global Historical Growth &

Transparency Market Research (TMR) announces a new report on the global cervical cancer vaccines market. The report presents detailed predictions regarding the growth of the cervical cancer vaccines market in the coming years, based on solid analysis of the market’s present and historical figures. The competitive and regional dynamics of the global cervical cancer vaccines market are also examined in the report, providing readers with a comprehensive overview of the market. The report is titled ‘Cervical Cancer Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.’

Request a Brochure of the Report @

Cervical cancer is an increasingly prevalent form of cancer and is found in women worldwide. It is closely associated with the human papillomavirus, as up to 99% cases of cervical cancer are accompanied by an HPV infection. Two high-risk types of HPV collectively account for more than 70% of cervical cancer cases in the world. As a result, HPV vaccines have been a key part of cervical cancer treatment and still account for a significant part of the treatment scenario of cervical cancer. Since October 2016, the CDC recommends that all individuals between the ages of 9 and 14 should receive two HPV vaccinations within six months.

The growing prevalence of cervical cancer in developing regions is a key driver for the global cervical cancer vaccines market. This has led to leading players in the global cervical cancer vaccine market trying to maximize their gains by developing low-cost cervical cancer vaccines. The cervical cancer vaccine market has also received stable assistance from government bodies as well as NGOs in recent years due to the rising severity of the problem, which is likely to remain a key driver for the global cervical cancer vaccine market in the coming years. While the high cost of the vaccines has kept them away from a considerable demographic in underdeveloped regions, the growing prevalence of the disease could force key players to boost their research investment in order to establish a firm position in populous markets such as Asia Pacific and Africa.

Request TOC @

By vaccine type, the global cervical cancer vaccine market is segmented into bivalent, quadrivalent, and 9-valent vaccines. Currently, the US FDA has only approved three cervical cancer vaccines, namely Cervarix, developed by GlaxoSmithKline, and Gardasil and Gardasil 9, developed by Merck & Co. Inc. Cervarix is a bivalent vaccine targeting two strains of HPV, namely HPV-16 and HPV-18. On the other hand, Gardasil is a quadrivalent vaccine and targets HPV-6 and HPV-11 in addition to HPV-16 and HPV-18.

The strong research and development scenario in the healthcare sector is likely to enable North America’s continued dominance in the global cervical cancer vaccines market in the coming years. The strong collaboration activities between public and private healthcare bodies in the region, united in developing effective vaccines against a range of diseases, is likely to remain a key driver for the cervical cancer vaccine market in North America. Nevertheless, the rising prevalence of cervical cancer in underdeveloped regions and the increasing attention being paid by the WHO to the problem is likely to drive the demand from the cervical cancer vaccine market in Asia Pacific, Africa, and Latin America in the coming years.

View This Report :

Apart from Merck and GlaxoSmithKline, ISA Pharmaceuticals BV is a rising name in the global cervical cancer vaccine market. Success of their immunotherapeutic cervical cancer vaccine, currently in phase II trials, would allow ISA Pharmaceuticals BV to take up a significant share in the global cervical cancer vaccine market in the coming years.

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cervical Cancer Vaccine Market:Global Historical Growth & Future Outlook (2017-2025) Demand Analysis & Opportunity Evaluation here

News-ID: 996384 • Views: 126

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases

More Releases for HPV

HPV Vaccines Market Insights by Size, Status and Forecast 2024
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs. More than 40 types of HPV viruses are easily transferred from one person to another by sexual
Cytology and HPV Testing Market - Research Analysis
The nature of the both the markets for cytology testing and HPV or human papillomavirus testing is oligopolistic in nature, states Transparency Market Research (TMR) in a research report. With the presence of only a handful of leading companies in the market, the competition is not that high as they compete among themselves with different or almost similar strategies. These few players are currently enjoying their reign in the global
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017
"The Report Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape. Human papillomavirus (HPV) is the most common viral infection
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,
HPV Testing Market 2017- Qiagen, Roche Diagnostics, Hologic
HPV Testing Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. “The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing,
New Research: Global Human Papillomavirus (HPV) Market
MarketResearchReports.Biz presents this most up-to-date research on "Human Papillomavirus (HPV)- Epidemiology Forecast To 2023" Latest Report, Human Papillomavirus (HPV) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Human Papillomavirus (HPV) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Human Papillomavirus (HPV) prevalent or incident cases segmented by age, sex and subpopulations. The